Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical Nutrition

Fat-free mass depletion in patients with COPD in Brazil: development of a new cutoff point and its relation with mortality and extrapulmonary manifestations

Abstract

Background/Objectives:

None of the cutoff points for fat-free mass index (FFMI) were tested for the Brazilian population, and it is unknown whether the available ones are able to discriminate extrapulmonary disease manifestations. This cross-sectional study aims to develop and validate a cutoff point for FFM depletion based on Brazilian patients with chronic obstructive pulmonary disease (COPD) and to verify its association and of previously published cutoffs with extrapulmonary manifestations.

Subjects/Methods:

A new cutoff point was obtained from the best FFMI value for discrimination of preserved exercise capacity in a sample of patients (n=57). The discriminative capacity was assessed in another sample (n=96). The new cutoff point and other previously published ones were tested to discriminate low exercise capacity, physical inactivity, sedentary lifestyle and low quality of life. A receiver operation characteristics curve with area under the curve (AUC) value was plotted and each cutoff points’ discriminative capacity was calculated. Cox regression and Kaplan–Meier method assessed the association between the cutoff points and mortality.

Results:

The new cutoff points for FFMI were 14.65 kg/m2 for women (AUC=0.744; sensitivity (Se)=0.88; specificity (Sp)=0.60) and 20.35 kg/m2 for men (AUC=0.565; Se=0.36; Sp=0.81). The new cutoffs were the best to discriminate poor exercise capacity assessed by walked distance in % predicted and quality of life. Only the new cutoff point was associated with mortality (HR=2.123; 95% CI: 1.03–4.33, P=0.039, log rank P=0.035).

Conclusions:

Only the new cutoff point was associated with all-cause mortality, and it had the highest discriminating capacity for exercise capacity and quality of life in Brazilian patients with COPD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016. Available at: http://www.goldcopd.org/.

  2. Wouters EFM . Chronic obstructive pulmonary disease: systemic effects of COPD. Thorax 2002; 57: 1067–1070.

    Article  CAS  Google Scholar 

  3. Kyle U, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM et al. Bioelectrical impedance analysis, Part I: Review of principles and methods. Clin Nutr 2004; 23: 1226–1243.

    Article  Google Scholar 

  4. Bosy-Westphal A, Müller MJ . Identification of skeletal muscle mass depletion across age and BMI groups in health and disease—there is need for a unified definition. Int J Obes 2015; 39: 379–386.

    Article  CAS  Google Scholar 

  5. Vermeeren MAP, Creutzberg EC, Schols AMWJ, Postma DS, Pieters WR, Roldaan AC et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006; 100: 1349–1355.

    Article  CAS  Google Scholar 

  6. Mostert R, Goris A, Weling-Scheepers C, Wouters EFM, Schols AMWJ . Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000; 94: 859–867.

    Article  CAS  Google Scholar 

  7. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample. Am J Respir Crit Care Med 2006; 173: 79–83.

    PubMed  Google Scholar 

  8. Schols AMWJ, Soeters PB, Dingemans AMC, Mostert R, Frantzen PJ, Wouters EFM . Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151–1156.

    Article  CAS  Google Scholar 

  9. Sabino PG, Silva BM, Brunetto AF . Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics 2010; 65: 599–605.

    Article  Google Scholar 

  10. Schols AM, Mostert R, Soeters PB, Wouters EF . Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991; 46: 695–699.

    Article  CAS  Google Scholar 

  11. Teopompi E, Tzani P, Aiello M, Ramponi S, Andrani F, Marangio E et al. Fat-free mass depletion is associated with poor exercise capacity irrespective of dynamic hyperinflation in COPD patients. Respir Care 2014; 59: 718–725.

    Article  Google Scholar 

  12. Kyle UG, Morabia A, Schutz Y, Pichard C . Sedentarism affects body fat mass index and fat-free mass index in adults aged 18 to 98 years. Nutrition 2004; 20: 255–260.

    Article  Google Scholar 

  13. Waschki B, Kirsten AM, Holz O, Mueller K-C, Schaper M, Sack A-L et al. Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192: 295–306.

    Article  Google Scholar 

  14. Andersson M, Slinde F, Grönberg AM, Svantesson U, Janson C, Emtner M . Physical activity level and its clinical correlates in chronic obstructive pulmonary disease: a cross-sectional study. Respir Res 2013; 14: 128.

    Article  Google Scholar 

  15. Schols AMWJ, Broekhuizen R, Weling-Scheepers CA, Wouters EF . Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53–59.

    Article  CAS  Google Scholar 

  16. Rutten EPA, Spruit MA, Wouters EFM . Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD. Respir Med 2010; 104: 91–98.

    Article  Google Scholar 

  17. Franssen FME, Rutten EPA, Groenen MTJ, Vanfleteren LE, Wouters EFM, Spruit MA . New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK Biobank. J Am Med Dir Assoc 2014; 15: 448.e1–448.e6.

    Article  Google Scholar 

  18. Probst VS, Kovelis D, Hernandes NA, Camillo CA, Cavalheri V, Pitta F . Effects of 2 exercise training programs on physical activity in daily life in patients with COPD. Respir Care 2011; 56: 1799–1807.

    Article  Google Scholar 

  19. Schutz Y, Kyle UUG, Pichard C . Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. Int J Obes Relat Metab Disord 2002; 26: 953–960.

    Article  CAS  Google Scholar 

  20. Kyle UG, Genton L, Gremion G, Slosman DO, Pichard C . Aging, physical activity and height-normalized body composition parameters. Clin Nutr 2004; 23: 79–88.

    Article  Google Scholar 

  21. Coin A, Sergi G, Minicuci N, Giannini S, Barbiero E, Manzato E et al. Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20–80 year-old Italian population. Clin Nutr 2008; 27: 87–94.

    Article  Google Scholar 

  22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.

    Article  CAS  Google Scholar 

  23. Pereira CAC, Sato T, Rodrigues SC . Novos valores de referência para espirometria forçada em brasileiros adultos de raça branca. J Bras Pneumol 2007; 33: 397–406.

    Article  Google Scholar 

  24. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA . Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 1986; 60: 1327–1332.

    Article  CAS  Google Scholar 

  25. Sousa TC, Jardim JR, Jones P . Validação do Questionário do Hospital Saint George na Doença Respiratória (SGRQ) em pacientes portadores de doença pulmonar obstrutiva crônica no Brasil. J Pneumol 2000; 26: 119–128.

    Article  Google Scholar 

  26. Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Pérez-Izquierdo J et al. Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 2010; 36: 292–300.

    Article  CAS  Google Scholar 

  27. Crapo RO, Casaburi R, Coates AL, Enright PL, MacIntyre NR, McKay RT et al. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117.

    Article  Google Scholar 

  28. Britto RR, Probst VS, de Andrade AFD, Samora GAR, Hernandes NA, Marinho PEM et al. Reference equations for the six-minute walk distance based on a Brazilian multicenter study. Braz J Phys Ther 17: 556–563.

    Article  Google Scholar 

  29. Troosters T, Gosselink R, Decramer M . Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 2: 270–274.

    Article  Google Scholar 

  30. Cote CG, Casanova C, Marin JM, Lopez MV, Pinto-Plata V, Oca MM et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 2008; 31: 571–578.

    Article  CAS  Google Scholar 

  31. Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T et al. An official European respiratory society statement on physical activity in COPD. Eur Respir J 2014; 44: 1521–1537.

    Article  Google Scholar 

  32. Furlanetto KC, Donária L, Schneider LP, Lopes JR, Ribeiro M, Fernandes KBP et al. How much time spent per day in sedentary behavior increases mortality risk in patients with COPD? In: ERS International Congress,vol. 48, Suppl. 60, 3–7 September 2016; Abstracts 2016..

  33. Altman DG, Bland JM . Diagnostic tests 2: predictive values. BMJ 1994; 309: 102.

    Article  CAS  Google Scholar 

  34. Altman DG . Practical Statistics for Medical Research, 1st edn. Champan & Hall/CRC: London, UK, 1991.

    Google Scholar 

  35. Baarends EM, Schols AMWJ, Mostert R, Wouters EF . Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2807–2813.

    Article  CAS  Google Scholar 

  36. Luo Y, Zhou L, Li Y, Guo S, Li X, Zheng J et al. Fat-free mass index for evaluating the nutritional status and disease severity in COPD. Respir Care 2016; 61: 680–688.

    Article  Google Scholar 

  37. Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S . Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 2007; 132: 164–169.

    Article  Google Scholar 

  38. Creutzberg EC, Wouters EFM, Mostert R, Weling-Scheepers CAPM, Schols AMWJ . Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003; 19: 120–127.

    Article  Google Scholar 

  39. Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF . Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995; 152: 1268–1274.

    Article  CAS  Google Scholar 

  40. Franssen FME, Broekhuizen R, Janssen PP, Wouters EFM, Schols AMW . Effects of whole body exercise training on body composition and functional capacity in normal weight patients with COPD. Chest 2004; 125: 2021–2028.

    Article  Google Scholar 

  41. Monteagudo M, Rodríguez-Blanco T, Llagostera M, Valero C, Bayona X, Ferrer M et al. Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med 2013; 107: 1589–1597.

    Article  Google Scholar 

  42. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP . Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856–1861.

    Article  CAS  Google Scholar 

  43. Lainscak M, Von Haehling S, Doehner W, Sarc I, Jeric T, Ziherl K et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2011; 2: 81–86.

    Article  Google Scholar 

  44. Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 2007; 101: 1954–1960.

    Article  Google Scholar 

  45. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P . Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002; 20: 539–544.

    Article  CAS  Google Scholar 

  46. Bigaard J, Frederiksen K, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL et al. Body fat and fat-free mass and all-cause mortality. Obes Res 2004; 12: 1042–1049.

    Article  Google Scholar 

  47. Rutten EPA, Calverley PMa, Casaburi R, Agusti A, Bakke P, Celli B et al. Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes. Ann Nutr Metab 2013; 63: 239–247.

    Article  CAS  Google Scholar 

  48. Slinde F, Grönberg A, Engström C-P, Rossander-Hulthén L, Larsson S . Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients. Respir Med 2005; 99: 1004–1009.

    Article  Google Scholar 

  49. Kyle UG, Piccoli A, Pichard C . Body composition measurements: interpretation finally made easy for clinical use. Curr Opin Clin Nutr Metab Care 2003; 6: 387–393.

    PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to the colleagues from the Laboratory of Research in Respiratory Physiotherapy and to Postgraduate programme in Rehabilitation Sciences UEL-UNOPAR. The project was supported by Araucaria Foundation (Paraná, Brazil). AT, AR, KCF, LD, GWB and AN are supported by grants from Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil). FP is supported by a research grant from National Council for Scientific and Technological Development (CNPq, Brazil).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F Pitta.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Travassos, A., Rodrigues, A., Furlanetto, K. et al. Fat-free mass depletion in patients with COPD in Brazil: development of a new cutoff point and its relation with mortality and extrapulmonary manifestations. Eur J Clin Nutr 71, 1285–1290 (2017). https://doi.org/10.1038/ejcn.2017.105

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2017.105

Search

Quick links